Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.88B | 3.94B | 3.78B | 3.61B | 2.91B |
Gross Profit | 1.50B | 1.59B | 1.31B | 1.31B | 1.05B |
EBITDA | 902.60M | 976.07M | 934.24M | 844.20M | 594.80M |
Net Income | 424.00M | 510.20M | 512.00M | 459.10M | 262.80M |
Balance Sheet | |||||
Total Assets | 5.23B | 4.91B | 4.48B | 4.24B | 4.09B |
Cash, Cash Equivalents and Short-Term Investments | 562.70M | 365.00M | 113.00M | 125.00M | 208.50M |
Total Debt | 1.21B | 1.20B | 1.14B | 955.50M | 922.60M |
Total Liabilities | 3.07B | 3.05B | 2.87B | 2.91B | 3.03B |
Stockholders Equity | 2.16B | 1.86B | 1.61B | 1.33B | 1.06B |
Cash Flow | |||||
Free Cash Flow | 380.60M | 464.90M | 7.80M | 497.50M | 666.70M |
Operating Cash Flow | 802.80M | 914.20M | 607.60M | 757.20M | 786.90M |
Investing Cash Flow | -446.70M | -470.50M | -660.10M | -348.20M | -120.40M |
Financing Cash Flow | -165.90M | -210.10M | -25.40M | -449.60M | -540.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $34.96B | 37.53 | 12.10% | 0.74% | -2.24% | 3.00% | |
76 Outperform | $6.82B | 15.18 | 33.52% | 0.48% | 0.05% | 0.96% | |
72 Outperform | $11.53B | 27.52 | 21.05% | ― | -1.59% | -15.58% | |
72 Outperform | $10.70B | 7.36 | 6.58% | 1.26% | -8.41% | 570.14% | |
70 Outperform | $33.62B | 32.06 | 11.88% | 0.57% | -0.54% | -48.61% | |
44 Neutral | C$967.22M | -6.71 | -13.35% | 2.72% | 17.20% | -32.62% | |
£46.21B | 18.60 | 15.72% | 1.35% | ― | ― |